Financials
- Fiscal year
- 2025
- Total assets
- €2.6m
- Profit
- €65,315
- Solvency
- 96.6%
Total assets▲ 0.5%
Net result
20182025
CLINIPHAR
ActiveSummary
CLINIPHAR has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €65,315. Equity is growing by ~3.4% per year across the filed fiscal years. Its solvency ranks better than 94% of 2603 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Overview
Activity
Medical imaging and medical laboratories
NACE 86910NACE 86901
#4 company by equity in Keerbergen, Health and social work sector1 site
Size
€2.6mtotal assets 2025
- Equity
- €2.5m
- Profit
- €65,315
Structure
Accounts on time0 of 4 deeds read
Why 92- Liquidity: current ratio 13.45, cash €66,783+ Sector Human health activities (NACE 86)+ Size: total assets €2.6m+ Figures for FY 2025 (filed 31-07-2026)Show the evidence
Checked score
Score 2025
92
/ 100
Excellent
Probability in this band: under 0.55%
Better than 40% of its sector peers (NACE 86, small)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency
100=
equity 96.6% of total assets
Liquidity
53-2
short-term debt 1.5% · cash 2.5%
Profitability
72+1
return on assets 2.5%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 17 months
06-2025: < 0.1%
07-2025: < 0.1%▲ +20.5% vs 06-2025
08-2025: 0.1%▲ +59.6% vs 07-2025highest value
09-2025: < 0.1%▼ -54.7% vs 08-2025
10-2025: < 0.1%● 0.0% vs 09-2025
11-2025: < 0.1%● 0.0% vs 10-2025
12-2025: < 0.1%● 0.0% vs 11-2025
01-2026: < 0.1%▼ -2.9% vs 12-2025
02-2026: < 0.1%● 0.0% vs 01-2026
03-2026: < 0.1%▲ +15.2% vs 02-2026
04-2026: < 0.1%● 0.0% vs 03-2026
05-2026: < 0.1%▲ +2.6% vs 04-2026
06-2026: < 0.1%● 0.0% vs 05-2026
07-2026: < 0.1%▲ +10.3% vs 06-2026
08-2026: < 0.1%▼ -39.5% vs 07-2026lowest value
09-2026: < 0.1%● 0.0% vs 08-2026lowest value
10-2026: < 0.1%● 0.0% vs 09-2026lowest value
- Sector Human health activities (NACE 86) lowers the probability
- Size: total assets €2.6m lowers the probability for this profile
- Figures for FY 2025 (filed 31-07-2026) lowers the probability
- Liquidity: current ratio 13.45, cash €66,783 raises the probability
Credit up to €230,000 at 30 days acceptable
Liquidity ample (current ratio 13.45 against 8.95 in 2024; short-term debt: 1.5% and cash: 2.5% of total assets), and 3.4% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, small). Better than this share of them on solvency 77%, liquidity 29%, profitability 23%, growth against the median 30%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
on the day
2023
16 d late
2022
31 d late
2021
34 d early
2020
53 d early
2019
30 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 10 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven monthsPosition in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · abbreviated…
- Annual accounts filedfiscal year 2024 · abbreviated…
- Annual accounts filedfiscal year 2023 · full…
Key points
By topic
Timeline
- Events
- 15
- Since
- 2017
- Next accounts
- by 31-07-2027
- 31-07-2026Annual accounts filed
- 31-07-2025Annual accounts filed
- 16-08-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Founded
- 28-12-2000
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.